Butink Maarten, Boekel Laura, Boonen Annelies, deRijk Angelique, Wolbink Gertjan, Webers Casper
Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Department of Social Medicine, Maastricht University, Maastricht, The Netherlands.
Rheumatol Adv Pract. 2024 Mar 9;8(2):rkae026. doi: 10.1093/rap/rkae026. eCollection 2024.
During the coronavirus disease 2019 (COVID-19) crisis, people with inflammatory rheumatic diseases (iRDs) might have been more vulnerable for adverse work outcomes (AWOs) and restrictions in work ability and work performance. Our objectives were to compare AWOs during the pandemic and current work ability between iRD patients and controls, understand which patients are most vulnerable for these outcomes and (3) explore the role of work characteristics on work performance while working remotely.
Patients and population controls in a Dutch COVID-19 cohort study provided information in March 2022 on work participation in March 2020 (pre-pandemic, retrospective) and March 2022 (current). AWOs comprised withdrawal from paid work, working hours reduction or long-term sick leave. Multivariable logistic/linear regression analyses compared outcomes (AWOs/work ability) between groups (patients/controls) and within patients.
Of the pre-pandemic working participants, 227/977 (23%) patients and 79/430 (18%) controls experienced AWOs following pandemic onset. A minority of AWOs (15%) were attributed to COVID-19. Patients were more likely to experience any-cause AWOs (odds ratio range 1.63-3.34) but not COVID-related AWOs, with female patients and patients with comorbidities or physically demanding jobs being most vulnerable. Current work ability was lower in female patients compared with controls [β = -0.66 (95% CI -0.92 to -0.40)]. In both groups, when working remotely, care for children and absence of colleagues had varying effects on work performance (positive 19% and 24%, negative 34% and 57%, respectively), while employer support and reduced commuting had mainly positive effects (83% and 86%, respectively).
During the pandemic, people with iRDs remained at increased risk of AWOs. COVID-related AWOs, however, were infrequent.
在2019年冠状病毒病（COVID-19）危机期间，患有炎性风湿性疾病（iRDs）的人可能更容易出现不良工作结局（AWOs）以及工作能力和工作表现受到限制。我们的目标是比较疫情期间iRD患者与对照组的AWOs及当前的工作能力，了解哪些患者最易出现这些结局，以及（3）探讨远程工作时工作特征对工作表现的作用。
荷兰COVID-19队列研究中的患者和人群对照组于2022年3月提供了关于2020年3月（疫情前，回顾性）和2022年3月（当前）工作参与情况的信息。AWOs包括退出有偿工作、减少工作时间或长期病假。多变量逻辑/线性回归分析比较了组间（患者/对照组）以及患者内部的结局（AWOs/工作能力）。
在疫情前有工作的参与者中，227/977（23%）名患者和79/430（18%）名对照组在疫情开始后经历了AWOs。少数AWOs（15%）归因于COVID-19。患者更有可能经历任何原因导致的AWOs（比值比范围为1.63 - 3.34），但不是与COVID相关的AWOs，女性患者以及患有合并症或从事体力要求高工作的患者最易出现这些情况。与对照组相比，女性患者当前的工作能力较低[β = -0.66（95%CI -0.92至 -0.40）]。在两组中，远程工作时，照顾孩子和同事不在对工作表现有不同影响（分别为正向影响19%和24%，负向影响34%和57%），而雇主支持和通勤时间减少主要有正向影响（分别为83%和86%）。
在疫情期间，患有iRDs的人出现AWOs的风险仍然增加。然而，与COVID相关的AWOs并不常见。
